Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

Clover Health Has a Bleak Present and Possibly a Bleaker Future

By Larry Ramer, InvestorPlace Contributor
Given the allegations against Clover Health, CLOV stock poses a great deal of risk. Investors should sell the shares.

MicroVision Seems Like the Honeypot of the Lidar Industry

By Josh Enomoto, InvestorPlace Contributor
MVIS stock might seem like a cheap speculation on the relevant lidar industry but the risk factors are piling up worrisomely.

Don’t Count on a Short Squeeze to Move Clover Health Stock

By Josh Enomoto, InvestorPlace Contributor
Though the short-squeeze idea has credibility with CLOV stock due to high short interest, you don’t want to depend solely on this trick.

Dump Sundial Growers Stock in Favor of Buying Retail Pure-Play Nova Cannabis

By Will Ashworth, InvestorPlace Contributor
Sundial Growers expects its acquisition of Inner Spirit to close in third quarter. Is SNDL stock the best Canadian cannabis retail option?

Reality Should Set-In For Those Buying-Into the BlackBerry Narrative

By Muslim Farooque, InvestorPlace Contributor
BB stock seems unlikely to mount a comeback based on its unclear business model and remarkably weak financial performance

The Bear Case on Clover Health Is Getting More Compelling

By Muslim Farooque, InvestorPlace Contributor
Growing cost of revenues and an unclear path to profitability makes it difficult to invest in CLOV Stock despite its potential

AMC Entertainment Is Playing a Movie That Won’t End Well

By Chris Markoch, InvestorPlace Contributor
Due to the new normal of streaming, AMC stock will be weighed down by negative earnings that will struggle to reach pre-pandemic levels.

Workhorse Looks Like It’s Probably Dead in the Water Here

By Larry Ramer, InvestorPlace Contributor
Workhorse's business has no meaningful, positive catalysts, and the hopes of WKHS stock bulls are unlikely to pan out.

ContextLogic Doesn’t Have the Fundamentals to Surprise as a Meme Stock

By Dana Blankenhorn, InvestorPlace Contributor
Redditors are picking up WISH stock based on a short squeeze, brought on by poor results in May. But the founder of ContextLogic has a different game in mind, international logistics.

When It Comes to AMC Stock, It’s a Matter of When, Not If

By Thomas Niel, InvestorPlace Contributor
Once Reddit traders fold, downside risk is massive. Given the likely net value of its operating business, shares could easily lose 80% of their value, and still be overpriced. If you got in this early, it's time to take profit. But, if you haven't got into AMC stock yet? With downside massive, and share price upside from here debatable, it's wise to stay away.

With the Squeeze Clearly Over, It’s Time to Ditch Clover

By Thomas Niel, InvestorPlace Contributor
Once traders who got into this short-squeeze situation cash out, CLOV stock appears destined to head back to around $7 per share.

Carnival’s Tough Challenges, Uncertain Outlook Make CCL Stock a Sell

By Larry Ramer, InvestorPlace Contributor
Among the hurdles faced by Carnival are its huge debt load and regulatory uncertainty. CCL stock should be sold by investors.

Lordstown Motors May Only Be the First Domino to Fall in the EV Sector

By Chris Markoch, InvestorPlace Contributor
RIDE stock is dropping on news that its pre-orders weren't binding commitments. In the speculative EV sector, Lordstown Motors will need to work hard to build investor trust.

The Owners of Bionano Stock Will Be Hurt by Dilution

By Alex Sirois, InvestorPlace Contributor
BNGO stock looks decent until you dive deeper and understand what's really going on. The shares' outlook isn't good.

It’s Time to Back Away From DraftKings Stock

By Dana Blankenhorn, InvestorPlace Contributor
The problem is with DraftKings' technology partner, SBTech, which short-sellers at Hindenburg Research say still does business where gambling is illegal.

Exercise Extreme Caution With Clover Health Stock

By Faizan Farooque, InvestorPlace Contributor
CLOV stock, like AMC and GameStop, is trading at an unrealistic valuation, and it's important to be cautious if you've already invested.

Senseonics Has Too Much Hope for Success Priced in Already

By Larry Ramer, InvestorPlace Contributor
Reddit investors might be weakening, and Senseonics has to contend with a tough competitor, making SENS stock unattractive.

The Risk-Reward Ratio of Zomedica Stock Looks Unfavorable

By Larry Ramer, InvestorPlace Contributor
Zomedica may have to contend with very difficult competition, and there are indications that Truforma is not very popular so far. ZOM stock looks very risky.

Vaxart Is Still Not Worth Anywhere Near Its Present Price

By Mark R. Hake, CFA
Vaxart is still not worth today's price. VXRT stock is worth no more than $6, especially if it's going to need another capital raise.
Load More Articles